| Frances Gibson, MA CCC-SLP | |
|
14035 Gardner Dr, Alpharetta, GA 30004-8602 | |
| (678) 366-9358 | |
| Not Available |
| Full Name | Frances Gibson |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 14035 Gardner Dr, Alpharetta, Georgia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245219146 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | SLP006038 (Georgia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Frances Gibson, MA CCC-SLP 14035 Gardner Dr, Alpharetta, GA 30004-8602 Ph: () - | Frances Gibson, MA CCC-SLP 14035 Gardner Dr, Alpharetta, GA 30004-8602 Ph: (678) 366-9358 |
News Archive
Fluctuations in blood composition that often arise from commonly used therapies among kidney disease patients are not an independent predictor of adverse outcomes for European hemodialysis patients, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology. The results suggest that although hemoglobin variability is common in kidney disease patients, it does not appear to increase their likelihood of dying early.
A new hard coating with antibacterial properties that has been tested by researchers at the UCL Eastman Dental Institute has been shown to kill 99.9% of Escherichia coli bacteria when a white hospital light was shone on its surface to activate it.
YM BioSciences Inc. today announced positive interim data from the first 60 patients enrolled in the Phase I/II trial for its JAK1/JAK2 inhibitor, CYT387, in myelofibrosis. The results were reported today in an oral presentation at the 52nd American Society of Hematology Annual Meeting being held in Orlando, Florida.
Dainippon Sumitomo Pharma Co., Ltd. announced today results from two Phase 3 clinical trials designed to evaluate the efficacy and safety of LATUDA as adjunctive therapy and monotherapy, respectively, in patients with bipolar I depression (PREVAIL 1 and PREVAIL 2; PRogram to EValuate the Antidepressant Impact of Lurasidone).
› Verified 7 days ago
Atlanta Speech Therapy, Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5905 Atlanta Hwy, Suite 101-12, Alpharetta, GA 30004 Phone: 404-939-1318 | |
Blaire Stoeck, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5755 N Point Pkwy, Suite 56, Alpharetta, GA 30022 Phone: 678-431-1301 Fax: 678-528-9612 | |
Ms. Patricia Taylor, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4080 Mcginnis Ferry Rd, Bldg.300, Ste.302, Alpharetta, GA 30005 Phone: 678-992-1935 Fax: 770-410-9510 | |
Michelle Harvey, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4080 Mcginnis Ferry Rd, Bldg 300 Ste 302, Alpharetta, GA 30005 Phone: 678-992-1935 Fax: 770-889-5584 | |
Ms. Dianne Olson Ely, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 805 Dockbridge Way, Alpharetta, GA 30004 Phone: 770-667-9832 | |
Fernando Rengifo-caicedo, SLP007041 Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 856 Red Hart Ln, Alpharetta, GA 30004 Phone: 202-297-5314 | |
Anna D White, M.ED. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6505 Shiloh Rd Ste 100, Alpharetta, GA 30005 Phone: 678-648-7644 |